Søren Vestergaard Rasmussen
Director, Neuroscience Discovery & Projects at Contera Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Peter Busk
Søren is a great scientist. He comes up with great ideas and knows how to make them into useful projects and products. In addition, he is intelligent and a very quick learner. When I had a problem I could not solve at Exiqon, I would ask Søren.
Torsten Due Bryld
Søren is a creative scientist with good communicaton skills and great enthusiasm
Peter Busk
Søren is a great scientist. He comes up with great ideas and knows how to make them into useful projects and products. In addition, he is intelligent and a very quick learner. When I had a problem I could not solve at Exiqon, I would ask Søren.
Torsten Due Bryld
Søren is a creative scientist with good communicaton skills and great enthusiasm
Peter Busk
Søren is a great scientist. He comes up with great ideas and knows how to make them into useful projects and products. In addition, he is intelligent and a very quick learner. When I had a problem I could not solve at Exiqon, I would ask Søren.
Torsten Due Bryld
Søren is a creative scientist with good communicaton skills and great enthusiasm
Peter Busk
Søren is a great scientist. He comes up with great ideas and knows how to make them into useful projects and products. In addition, he is intelligent and a very quick learner. When I had a problem I could not solve at Exiqon, I would ask Søren.
Torsten Due Bryld
Søren is a creative scientist with good communicaton skills and great enthusiasm
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Contera Pharma
-
Denmark
-
Biotechnology
-
1 - 100 Employee
-
Director, Neuroscience Discovery & Projects
-
Feb 2021 - Present
-
-
-
Roche
-
Switzerland
-
Biotechnology Research
-
700 & Above Employee
-
Senior Principal Scientist
-
Oct 2019 - Feb 2021
Technical project lead on CNS drug discovery project. Member of global project teams.
-
-
Technology Officer
-
Feb 2019 - Feb 2021
Driving technology improvements. (Tox, PK/PD etc.)Expanding ASO platform beyond traditional gapmers.Identification and evaluation of external opportunities within RNA therapeutics.Permanent member of RMR governance board.
-
-
Principal Scientist | Project Manager
-
Nov 2015 - Sep 2019
- Establishing CNS drug discovery platform for oligonucleotides. - Technical project leader for Ube3a ASO program, entering clinic summer 2020.
-
-
-
Lundbeck
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Research Scientist | Project leader
-
Apr 2013 - Oct 2015
-Project leader of drug discovery project (depression) and leader of core project team consisting of project managers from chemistry, molecular pharmacology, biology, toxicology and PK. -Bioscience leader for early project within depression.-Mode action studies/prelaunch preclinical studies for a new atypical antipsychotic.
-
-
Research Scientist
-
Jul 2010 - Mar 2013
Project manager of ‘Interneuron platform’ target identification project (Schizophrenia, NF1, autism, trisomy 21, fragile X). Developing in vitro assays for target identification within Schizophrenia using HCS and Ca2+ flux in primary neuronal cultures.
-
-
Research Academic
-
Oct 2008 - Jun 2010
Heading Lundbecks activities in HTF (Advanced Technology Foundation) “Novel medicines”. Public private partnership project. Collaborating with two academic labs and two biotech companies. Establishing HCS screening assays in primary neuronal cultures, Schizophrenia relevant phenotypes.
-
-
-
Exiqon
-
United States
-
Research Services
-
Senior Scientist
-
2006 - Sep 2008
Team leader of microarray development team: 6 Ph.D. level scientists: molecular biologists, bioinfomaticians and organic chemist. Receiving a four year 680,000 € grant as Exiqon PI for FP7 application “OncomiRs”. Product launch Team leader for the miRNA knock down product line, coordinating product launch activities across R&D, Sales and Marketing and Production. Team leader of microarray development team: 6 Ph.D. level scientists: molecular biologists, bioinfomaticians and organic chemist. Receiving a four year 680,000 € grant as Exiqon PI for FP7 application “OncomiRs”. Product launch Team leader for the miRNA knock down product line, coordinating product launch activities across R&D, Sales and Marketing and Production.
-
-
-
Karolinska Institute
-
Sweden
-
Research
-
1 - 100 Employee
-
Post doc
-
2005 - 2006
-
-
-
Aarhus University
-
Denmark
-
Research
-
700 & Above Employee
-
Post Doc
-
2003 - 2005
-
-
-
århus university
-
Public Policy Offices
-
ph d student
-
1999 - 2003
-
-
Education
-
Aarhus University